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ABSTRACT
For the purpose of investigating the effects of iron supplementation on the therapy of experimental
canine ancylostomosis, twenty 8-week old pups were rando mly divided into four equal groups A, B,
C and D. Groups A, B and C were serially infected bi-weekly with infective Ancylostoma caninum
(L3) larvae up to 98 days. Thereafter, Groups A and B were treated with pyrantel pamoate and dextrose
saline infusion with or without iron dextran supplementation, respectively. Pups in Group C were left
untreated as were the uninfected control pups in Group D. Clinical observations revealed a serial
reversion of the distressing hookworm disease signs in only the two infected and treated Groups A and
B, but not in the infected but untreated pups in Group C. Both the haematological, and immunological
parameters were most elevated in the iron-treated pups in Group A, with high and positive correlation
coefficient (r) of + 0.94, 0.83, 0.41 and 0.98 for the respective Groups A, B, C and D. Iron therapy was
suggested as being responsible for the prompt haematological and immunological reversion observed
in Group A pups through its facilitation of the haemoglobin synthesis and the iron-dependent mitotic
cell division processes.
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Introduction
Ancylostomosis in susceptible dogs is accompanied by the development
of a microcytic and hypochromic (iron deficiency) anaemia due to the
depletion of the body’s iron by both the blood sucking habits of the worms,
as well as to bleeding of intestinal bite wounds (KELLY et al., 1977; HOTEZ
and CERAMI, 1983). The severity of such anaemia bears a positive correlation
to the degree of worm infection (CARROLL and GROVE, 1984) especially in
the more susceptible young pups with very low body iron reserves resulting
from lower dietary iron intake, which in turn reflects their exclusive feeding
on the dam’s milk (OFTEDAL, 1984).
Ancylostoma caninum, the most common pathogenic hookworm of
dog, can cause a daily loss of 0.01 to 0.2 ml of blood for each adult worm,
which can result in the daily loss of 25% or more of the host animal’s total
blood volume (MILLER, 1966; MILLER, 1971). Given the iron content of whole
blood as 40-60 mg per 100 ml (LATNER, 1975), the iron loss in
ancylostomosis is colossal.
In addition to the iron deficiency anaemia, ancylostomosis precipitates
a gradual state of secondary immunodeficiency which positively correlates
with the degree of anaemia (KELLY et al., 1977). Iron deficiency is known to
cause tissue defects in mammals and it has been suggested that these might
be related to impairment of the iron-dependent enzyme system in cells
(other than stem cells) such as those that are involved in DNA synthesis
and mitotic process (ROBBINS and PEDERSON, 1970; HERSHKO et al., 1970).
JOYNSON et al. (1972) convincingly demonstrated a significant in vitro
impairment of lymphocyte transformation and macrophage inhibition factor
production (Correlates of cell-mediated immune (CMI) responses) in iron-
deficient patients suffering from microcytic and hypochromic anaemia.
This finding was soon corroborated by HIGGS and WELLS (1972), and KELLY
(1973).
Clinically, acquired resistance to infection which accrues to pups by
virtue of their age and previous exposure (MILLER, 1964; CARROLL and
GROVE, 1985; OKEWOLE and ODUYE, 2001) and the iron supplemented
anthelmintic removal of the blood-sucking adult worms have been reported
to restore the haematological derangement (PCV or Hb. Conc.) in the
hookworm infected pups (FOY and KONDI, 1960; CARROLL and GROVE, 1986).
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The ability of the same iron supplementation therapy to reverse the
immunological derangement also had been suggested (JOYNSON et al., 1972;
KELLY et al., 1977), although its experimental proof has not been convincingly
and simultaneously demonstrated in different groups of animals.
Taking the lymphocyte blastogenesis as a typical representation of the
immunological changes in ancylostomosis, in vitro mitogenic (antigenic)
stimulation tests could be performed on whole blood or separated
lymphocytes from experimentally infected and iron treated pups in order
to evaluate and compare their haematological and immunological
responses.
The aim of this study was to evaluate the role of iron supplemented
anthelmintic therapy in the reversal of haematological and immunological
derangements that accompany canine ancylostomosis.
Materials and methods
Animals. Twenty, 8-week old local mongrel pups, whelped in our
kennel, were used for the study. They were treated twice with pyrantel
pamoate (Canex® Pfizer, Australia) at a dose rate of
 5 mg kg-1 at 2-week intervals. They were negative for nematode ova by
the flotation method.
Experimental design. The 20 pups were randomly divided into 4 groups,
A, B, C and D of 5 pups each. Each group was kept separately on zinc-
floored kennels to facilitate total faecal recovery and they were fed balanced
rice-based pasty formulated food; supplemented twice weekly with re-
constituted dry full-cream milk (Glaxo Nig. Ltd.) and fish meal. Groups
A, B and C pups were subcutaneously infected with 500 infective larvae
(L3) of Ancylostoma caninum biweekly from days 0 to 98, while the group
D pups were kept as uninfected controls. On day 100, Group A pups were
treated with oral pyrantel pamoate (Canex®-Pfizer) at the above stated
dosage, intramuscular injection of iron dextran (Ronidex®-Dizengoff.WA
Nig. Ltd.) at a dose rate of 10.0 mg of elemental iron kg-1 body mass twice
daily from days 100 to 114 (DODDS and WARD, 1980). The pups were also
intravenously rehydrated with Dextrose-Saline infusion (Unidexral®-
Unique Pharma Ltd.) as clinically indicated. Group B pups were treated in
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the same way as their Group A counterparts but with no iron dextran
supplementation. The infected Group C pups were left untreated, as were
the uninfected Group D pups.
Clinical, haematological, coprological and immunological observations
were made on all groups until day 126.
Parasites. Infective (3rd stage) larvae (L3) of Ancylostoma caninum
were obtained from a culture of ova in faecal samples from 4 naturally
infected local pups from the Ibadan metropolis. The detailed culture
technique, larval harvesting, washing, dilution, dosaging and the
subcutaneous infection methods were as previously described (MILLER,
1964).
Haematology. Blood samples from each pup were taken every other
week, anticoagulated with EDTA and analyzed with electronic coulter
counter S-plus® (Coulter Electronics, Hialeah, Fla). Haemoglobin (Hb)
concentration, haematocrit value (PCV%), total red and white blood cell
counts were estimated, while the mean corpuscular volume (MCV) was
calculated. Differential leukocyte counts were performed on heparinized
blood on an improved Neubauer haemacytometer after staining with new
Carpentier’s stain (CARROLL and GROOVE, 1984).
Estimation of worm egg production rate. Worm eggs per gramme of
faeces were also simultaneously estimated biweekly using the modified
Mc Master slide counting technique, according to the Manual of Veterinary
Parasitological Laboratory Technique (MAFF, 1986).
Peripheral lymphocyte transformation study. The whole blood method
was used to determine the response of dog lymphocyte to stimulation by a
T-cell mitogen; soluble phytoheamagglutinin P (PHA) - (Difco laboratory,
Detroit) on a biweekly basis for the 4 groups of pups. This method has the
advantage of eliminating the necessity for the separation and purification
of lymphocytes (COLGROVE, 1978). Also, erythrocytes in the whole blood
cultures provide a desirable environment for lymphocyte activation
(PAULEY et al., 1973).
Lymphocyte culture. In a preliminary experiment designed to establish
optimal culture conditions with normal dogs, serial dilutions of blood from
normal dogs expressed in cell density (lymphocyte/ml) were titrated against
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varying doses of PHA (1.5 - 250 µg). A dose-response relationship (curve)
was established between concentrations of PHA and lymphocyte counts
(mean counts per minute from triplicate cultures). The relationship revealed
that 20 µg PHA dose level was the most sensitive in detecting small changes
in responsiveness and that the curve kurtosis reflects changes in the relative
and absolute numbers of reactive cells, thus presenting the curve as a useful
device for monitoring the profile of peripheral blood lymphocytes (KENNY,
1975).
Twenty-five microlitres of heparinized blood from each pup were
placed in a polypropylene tube containing 0.5 ml of culture medium: [RPMI
1640 buffered with 28 mM, HEPES-N-2-hydroxyethyl piperazine-N-2-
ethane sulfonic acid, (Sigma Pty Ltd.) plus penicillin G (100 µg/ml)
streptomycin (100 µg/ml), and 25 microlitres of various stock solutions of
PHA (Difco labs., Michigan)] to give the following final concentrations;
2.5 µg, 5.0 µg, 10.0 µg and 20.0 µg per culture. Triplicate cultures for
each dose of PHA were set up and 25 microlitres of normal saline in tubes
provided unstimulated control for each set. Tubes were tightly capped,
kept upright and incubated at 37 oC, under an atmosphere of 5% CO2 in air
for 24 hours before its radiochemical labelling to monitor DNA synthesis
in the T-cells.
Labelling and harvesting procedures. At the end of the first 24-hour
incubation period, 2.0 µCi of tritiated thymidine (TRA-120 Radiochemical
Centre, Amersham, UK) (specific activity 5 ci/mM) was added to each
culture before being further incubated for another 24 hours. The detailed
descriptions of the harvest procedures were a modification of those
previously given by PAULEY et al. (1973). In brief, cells were resuspended
and 6.0 ml of normal saline were added to each. Erythrocytes were lysed
with 2.0 ml of 2% acetic acid by Vortex mixer under agitation. Supernatant
was removed and the pellet was suspended and spun in 5% trichloroacetic
acid (TCA) and methanol. Pellet was finally dissolved in 0.5 ml hyamine
hydroxide (Hyamine 10x-P), incubated at 56 oC for 20 minutes before
transfer into scintillation vials. The incorporation of [3H] thymidine (which
correlates with the rate of DNA synthesis) was determined with the aid of
a scintillation spectrometer (Tri-carb liquid scintillation spectrometer-
Packard Instruments, Downers Grove, Illinois) with external
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standardisation. The PHA dose-response curves were drawn for group mean
counts of lymphocytes per minute against PHA concentrations, and the 20
µg dose response was statistically fixed as the optimum for group
comparison of responses. An index of responsiveness (IR) takes into
account the different lymphocyte counts on a biweekly basis and is
expressed as mean counts per minute per 1×106 lymphocytes.
Statistics. All results were expressed as means ± standard deviations.
All tests of significance were performed, using the two-tailed Student’s t-
test, at 5% level of significance, unless otherwise indicated. Statistical
analysis was done on a SAS (1987), ver. 6.03 Statistical Analysis System
Institute, Cary, North Carolina, U.S.A.
Results
Clinical observations. Days 0 to 28 were uneventful in the 3 infected
Groups, A, B and C, but from days 65 to 100, 4, 3 and 4 pups from groups
A, B and C, respectively came down with watery and slightly bloody
diarrhoea. Groups A and B pups in particular were severely dehydrated,
weak, inappetent, emaciated, pale and with cold extremities of the legs
(group mean rectal temperature (GMRT) was 37.4 ± 1.8 oC). Group C
pups also had intermittent bloody diarrhoea, dyspnea, weakness, pallor of
visible mucosae and fairly cold extremities, GMRT was 37.8 ± 1.2.
Diarrhoea became more bloody and regular in Group C pups from days
103 to 126, with 4 of the 5 pups being seriously dehydrated, weak, anorexic,
dyspnoeic and in sternal recumbency. In contrast, Group D pups were
healthy, alert, groomed and growing, especially from day 50 to day 126.
GMRT was 38.7 ± 1.6 oC.
However, the clinical picture in pups in Groups A and B became
reversed from days 107 to 126, with improved appetite, alertness, vigour
and the groomed nature of hair coat. Extremities were normally warm,
with GMRT at 38.8 ± 1.3 oC. Visible mucosae were pink and liveweight
gain was clinically evident, especially in Group A pups.
Haematological findings. Haemoglobin concentration (Hb.conc),
haematocrit value (PCV%) and total red cell counts (RBC counts) were
almost invariably constant from days 0 to 28 in the 4 groups, but the same
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parameters, as well as the MCV, steadily declined from days 29 to 98,
only to increase variously prior to day 126, especially in Group A pups.
(Table 1 and Fig. 1). However, the Hb. Conc. rose rapidly in response to
the iron therapy in Group A pups to about its initial value at day 126.
These parameters decreased considerably from days 56 to 126 in Group C
pups, contrasting greatly with the situation in Group D, where they
increased steadily until day 126. Reticulocytosis and thrombocytosis were
observed from days 47 to 112 in pups in Groups A, B and C. Leukocytic
changes consisted of typical left shift with neutrophilic leukocytosis, as
well as persistent eosinophilia in the three infected groups from days 54 to
98, more particularly in Group C pups.
Days post infection 
Groups Unit  
0 14 28 42 56 70 84 112 126 
Group A 
(n=5) ×10
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Group C 
(n=5) ×10
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Group D 
(n=5) ×10


















Worm egg production rate. Worm egg production rate was divisible
into three phases in this study viz. the pre-patent phase when no eggs were
seen in faeces (days 0 to 28), the early patent phase when eggs were seen
at an increasing rate (days 29 to 110), and the late patent phase when egg
production declined slightly (days 111 to 126). These 3 phases were
identifiable in the 3 infected groups. The control pups had no eggs in
faeces (Table 1).
Table 2. Index of responsiveness (IR) expressed as group mean counts of peripheral
lymphocyte in response to 20 µg dose of phytohaemaglutinin (PHA) in dogs serially
infected with A. caninum larvae
Values are expressed as means ± standard deviations
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T-lymphocyte transformation responses to PHA stimulation. The group
mean index of responsiveness (GMIR), measured as group mean of T-cell
counts per minute per 106 lymphocytes of triplicate culture, correlated
positively with the group mean haemoglobin concentration (GMHC) at
the patent phase of the serial infection (days 42-126) with the following
correlation coefficients (r) +0.94, +0.83, +0.49 and 0.98 for Groups A, B,
C and D pups, respectively, at 5% level of significance. There was an
initial elevation of response to PHA stimulation from days 0 to 14 in the
three infected groups, followed by an increased impairment as the infection
load increased and anaemia intensified with time (Table 2). However, the
IR, like the Hb. Conc. values, increased terminally from days 110 to 126
in the iron-treated Group A pups than they did in the other two infected
Groups (B and C) without iron supplementation. Group D pups had
consistently high IR values, as with the corresponding Hb. Conc. values,
until day 126 to justify its positive and highest coefficient (r) (Table 2).
 Effect of Pup group pairing p-Value t-Value Interpretation 
a. 
Infection of A. caninum on the 
haemoglobin concentration (Hb. Conc.) 
values. GMPV of Hb. Conc. in the 
group 
C versus D 0.001 -5.920 




Serial infection of A. caninum on the IR 
of T-cells to PHA stimulation, GMPV 
of the IR in the group 
C versus D 0.001 -15.493 




General anthelmintic treatment on Hb. 
Conc. values, GMPV of the Hb. Conc. 
in the group  
B versus C 0.003 1.775 B was significantly higher than C 
d. 
General anthelmintic treatment on the 
IR of T-cells to PHA stimulation, 
GMPV of the IR in the group 
B versus C 0.002 5.787 




Iron supplementation therapy on the 
Hb. Conc. values, GMPV of the Hb. 
Conc. in the group 
A versus B 0.150 1.573 




Iron supplementation therapy on the IR 
of T-cells to PHA stimulation, GMPV 
of the IR in the group 
A versus B 0.609 0.543 




Table 3. Statistical comparison of the pooled group mean patent values (GMPV) of
some haematological and immunological parameters for pup groups
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Statistical analysis. The pooled group mean patent values (GMPV)
from days 42 to 126 in Tables 1 and 2 were used for the tabulated statistical
comparisons in Table 3.
Discussion
This study has corroborated the previous observations of MILLER (1966),
KELLY et al. (1977), and OKEWOLE and ODUYE (2001) in that serial infection
of pups with the infective larvae of A. caninum culminated in the
development of a microcytic and hypochromic (iron-deficiency) type of
anaemia. The severity of anaemia, as revealed by the GMHC depletion,
increased with infection load and time, the development was terminable
with an anthelmintic therapy and reversible when the latter is combined
with iron supplementation therapy.
The high and positive correlation coefficient (r) between the GMHC
and the GMIR of the T-cells to the PHA stimulation, especially in Group A
pups (Fig. 1), was statistically suggestive of the possibility of the above
treatment protocols similarly affecting both haemoglobin and IR variables.
The iron depletion that went concomitantly with whole blood loss as
infection intensified with time had been agreed as the link between these
two variables (HERSHKO et al., 1970; JOYNSON et al., 1972; KELLY, 1973; KELLY
et al., 1977; VALL and PARRY, 1991) but the relative sensitivity of each to iron
depletion and replenishment has not been adequately elucidated. According
to JAIN (1986), iron depletion retards the synthesis of haemoglobin through
the impairment of DNA synthesis, thus leading to a condition where the
nucleus is retained longer than in the normal erythrocytic maturation
sequence. This allows for further cell division and smaller than normal
definitive red cells (microcytic) with less haemoglobin (hypochromic) than
normal. Similarly, ROBBINS and PEDERSON (1970) suggested a crucial role
for iron in mitosis. These workers observed that most cellular iron is bound
to polysaccharides and that the addition of an iron chelating agent to living
cells selectively inhibited the DNA synthesis, when monitored by rate of
[3H]-thymidine incorporation, as done in this study also. They concluded
that the interphase nucleolus and metaphase chromosomes are particularly
enriched iron depots, and that iron moves from one site to the other at
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different phases of the cell cycle for successful DNA synthesis and cell
division, through the election transferring activities of the iron-dependent
cytochrome oxidase systems. The serial iron depletion in these infected
pups might have reduced the iron needed for cytochrome oxidative activities
and so retarded or arrested the mitosis of the T-cells, while its therapeutic
replenishment reversed these trends.
The return of both the GMHC and the GMIR of T-cells to about their
initial values in Group A pups underscores the crucial adjunctive role of
iron supplementation therapy in the management of canine ancylostomosis.
By implication, such valuable iron disposition also stresses the need for
an adequate dietary source of iron, especially to recently weaned pups
that might have been fed exclusively on iron-deficient dam’s milk
(OFTEDAL, 1984) as recently emphasized (VARAYAN and BANWELL, 1982;
CHANDRA, 1991).
Clinically, a diagnostic advantage of the high and positive correlation
coefficient (r) between the GMHC and GMIR could be taken, since the
former is practically easier to determine in order to estimate the latter,
which represented the cell-mediated component of the total protective
immunity (SMITH et al., 1970). However, the results of such correlation-
derived values of GMIR should be interpreted with caution since previous
medical treatment (TAJIMA et al., 1989) and the physiological state of the
animals (KUHN and HARDEGG, 1992) have been reported to influence its
values.
The statistically insignificant difference between Groups A and B values
for the effects of iron therapy on both the GMHC and GMIR (Table 3)
might be apparent and actually relate to the very late administration of
iron during patency, which statistically reduced its enhancement effects
on both variables on a D.42 to D.126 patency range. The choice of the
intramuscular route for such an enhancing iron therapy (as opposed to the
recommended safer and practical oral route (HARVEY et al., 1982) was made
taking into account the caution to avoid the possible absorptive barrier
that might be created by the inflamed intestinal mucosae. However, such
route could be toxic, if unnecessarily prolonged (HARVEY et al., 1982).
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SAŽETAK
U pokusu odreðivanja uèinka dodatka željeza na terapiju pokusno izazvane ankilostomoze pasa,
20 štenadi u dobi 8 tj. bilo je podijeljeno u èetiri skupine oznaèene A, B, C i D. Skupine A, B i C bile
su svaka dva tjedna invadirane invazijskim lièinkama Ancylostoma caninum (lièinke 3. stupnja) u
razdoblju 98 dana. Nakon invazije skupine A i B bile su lijeèene pirantel pamoatom i infuzijama
fiziološke otopine dekstroze s dodatkom ili bez dodatka željeza  i dekstrana. Skupina C i kontrolna
skupina D nisu bile lijeèene. Ustanovljeno je znatno poboljšanje klinièkih znakova bolesti u štenadi
skupine A i B, ali ne i u invadirane i nelijeèene štenadi skupine C. Vrijednosti imunoloških i
hematoloških pokazatelja  bile su mnogo više u skupini A lijeèenoj željezom s visokim i pozitivnim
korelacijskim koeficijentom (r) od +0,94, 0,83, 0,41 i 0,98 za odgovarajuæe skupine A, B, C i D.
Smatra se da je terapija željezom, putem olakšane sinteze hemoglobina i o željezu ovisnih procesa
mitoze,  dovela do brzog poboljšanja hematoloških i imunoloških pokazatelja u štenadi skupine A.
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